Victory Capital Management Inc Solid Biosciences Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$0.43 - $1.24 $78 - $226	183 Added 1.59%	11,728 $7,000
Q1 2022 May 04, 2022	SELL	$0.74 - $1.79 $243 - $588	-329 Reduced 2.77%	11,545 $6,000
Q4 2021 Feb 07, 2022	SELL	$1.69 - $2.46 $623 - $907	-369 Reduced 3.01%	11,874 $21,000
Q3 2021 Nov 02, 2021	SELL	$2.38 - $3.77 $1,470 - $2,329	-618 Reduced 4.81%	12,243 $29,000
Q2 2021 Aug 03, 2021	BUY	$3.49 - $5.51 $44,884 - $70,864	12,861 New	12,861 $47,000
Q2 2020 Aug 07, 2020	SELL	$2.1 - $3.42 $10,371 - $16,891	-4,939 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.31 - $4.43 $258 - $496	-112 Reduced 2.22%	4,939 $12,000
Q4 2019 Feb 04, 2020	BUY	$2.82 - $12.9 $9,029 - $41,305	3,202 Added 173.17%	5,051 $17,000
Q3 2019 Nov 12, 2019	BUY	$4.33 - $11.64 $8,006 - $21,522	1,849 New	1,849 $19,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.